IN168257B - - Google Patents

Info

Publication number
IN168257B
IN168257B IN721/CAL/88A IN721CA1988A IN168257B IN 168257 B IN168257 B IN 168257B IN 721CA1988 A IN721CA1988 A IN 721CA1988A IN 168257 B IN168257 B IN 168257B
Authority
IN
India
Application number
IN721/CAL/88A
Other languages
English (en)
Inventor
David Mirelman
Meir Wilchek
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of IN168257B publication Critical patent/IN168257B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN721/CAL/88A 1987-08-31 1988-08-30 IN168257B (en])

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL83715A IL83715A0 (en) 1987-08-31 1987-08-31 Pharmaceutical anti-protozoal compositions

Publications (1)

Publication Number Publication Date
IN168257B true IN168257B (en]) 1991-03-02

Family

ID=11058131

Family Applications (1)

Application Number Title Priority Date Filing Date
IN721/CAL/88A IN168257B (en]) 1987-08-31 1988-08-30

Country Status (3)

Country Link
EP (1) EP0305968A3 (en])
IL (1) IL83715A0 (en])
IN (1) IN168257B (en])

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69118188T2 (de) * 1990-07-26 1996-10-31 Monsanto Co., St. Louis, Mo. Verfahren zur herstellung vernetzter polyamine
IL109519A (en) * 1994-05-03 1999-03-12 Yeda Res & Dev Vaccines for oral immunization against infecting agents
JPH107575A (ja) * 1996-06-21 1998-01-13 Synsorb Biotec Inc 細菌性赤痢の処置
IL127649A0 (en) * 1996-06-21 1999-10-28 Synsorb Biotech Inc Use of oligosaccharides for neutralising e. coli toxins
FR2819507B1 (fr) * 2001-01-17 2007-09-28 Inst Rech Developpement Ird Quinoleines substituees pour le traitement de co-infections a protozoaires et a retrovirus
GB0122793D0 (en) * 2001-09-21 2001-11-14 Stone Island Holdings Ltd Allicin
GB0821928D0 (en) * 2008-12-01 2009-01-07 Isis Innovation Antibiotic nanomaterial
WO2015004133A1 (en) 2013-07-08 2015-01-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for performing antisense oligonucleotide-mediated exon skipping in the retina of a subject in need thereof
CN104557715B (zh) * 2014-12-23 2017-01-11 齐鲁晟华制药有限公司 一种二丙酸咪唑苯脲无菌原料药的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1590574A (en) * 1976-08-06 1981-06-03 Atomic Energy Authority Uk Biologically active gels
DD137186A1 (de) * 1978-06-30 1979-08-22 Guenther Magister Verfahren zur herstellung von rieselfaehigen produkten aus zellulosepulver
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
DE3012825A1 (de) * 1980-04-02 1981-10-08 Bayer Ag, 5090 Leverkusen Protozoenmittel, verfahren zu seiner herstellung sowie seine verwendung
DE3230736A1 (de) * 1982-08-18 1984-02-23 Herbert Prof. Dr. 8400 Regensburg Rupprecht An siliciumdioxid als traeger gebundene wirkstoffe, verfahren zu ihrer herstellung und ihre verwendung
US4728664A (en) * 1985-08-28 1988-03-01 Merck & Co., Inc. Uniquely non-mutagenic substituted nitroimidazole

Also Published As

Publication number Publication date
IL83715A0 (en) 1988-01-31
EP0305968A2 (en) 1989-03-08
EP0305968A3 (en) 1989-04-05

Similar Documents

Publication Publication Date Title
IN170871B (en])
FR2624313B1 (en])
IN171716B (en])
IN168257B (en])
IN172180B (en])
IN171862B (en])
IN169717B (en])
GR871557B (en])
IN172315B (en])
IN170873B (en])
IN170537B (en])
IN163620B (en])
BG45243A1 (en])
BG45051A1 (en])
BG45191A1 (en])
BG44788A1 (en])
BG44639A1 (en])
BG44614A1 (en])
BG44585A1 (en])
BG45377A1 (en])
BG45326A1 (en])
BG45305A1 (en])
BG45284A1 (en])
BG45283A1 (en])
BG45194A1 (en])